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• Australia’s efforts to prevent, diagnose and treat cancer are 
not as successful for Aboriginal and Torres Strait Islander 
people as they are for other Australians.
• There is a need for a nationally coordinated, collaborative, 
priority-driven research effort to better understand what 
works, and we need to implement that knowledge.
• All aspects of the process must involve genuine Indigenous 
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Indigenous Australians, and accounts for a greater number of
deaths each year than diabetes and kidney disease.1 Indigenous
Australians experience a higher incidence of high-fatality cancers,
their cancers tend to have reached more advanced stages at
diagnosis, and they have greater levels of comorbid illness, poorer
access to care and less comprehensive treatment.2,3 In addition,
many potentially preventable or screen-detectable cancers are
more common among Indigenous Australians.2,3
Complicating these figures is the fact that many Indigenous
cancer patients are not identified as such in the state and territory
cancer registries that are the key sources of basic statistical data on
cancer patterns.1-3 This means that the burden of cancer among
Indigenous Australians continues to be underestimated.
This broad picture suggests a widespread failure of the health
system to prevent, diagnose and treat cancer among Indigenous
Australians.2,3 Although the need to improve cancer-related health
services for Indigenous Australians is apparent, the available
evidence is currently inadequate to direct such efforts. For exam-
ple, we know little about the availability of Indigenous-specific
cancer support services,4 which models of care are most effective,
or the needs of Indigenous cancer patients and what their families
need to do in order to engage productively with health services.5
Neither do we know enough about the potentially modifiable
factors related to health services design and delivery that are
associated with poorer cancer outcomes. For many Indigenous
people, cancer is seen as a death sentence and treatment is
therefore not always regarded as a high priority.6 Competing social,
cultural and family demands as well as inadequate communication
between health service providers and Indigenous people may also
result in less comprehensive cancer treatment.
In order to improve the performance of the health system for
Indigenous people with cancer, we need to know more about what
works, and we need to ensure that such knowledge influences policy
and practice. Although there have been improvements in some areas
affecting cancer outcomes for Indigenous Australians (eg, greater
attention to the cultural sensitivity of screening programs3,5), there
has not been a national effort to measure the effects of these and
other interventions, nor sufficient research to guide priorities. For
example, one of the most obvious ways to improve Indigenous
health is to reduce smoking, yet until recently,7 there have been few
resources dedicated to Indigenous tobacco control programs, and
even fewer to enable the success or otherwise of such initiatives to be
evaluated.3 Recent developments suggest that the time is right to
make substantial gains through a coordinated, priority-driven
research effort. This should involve a collaborative partnership of
researchers, policymakers, service providers and consumers, with
substantial Indigenous input and leadership.
In December 2010, the Lowitja Institute, Australia’s National
Institute for Aboriginal and Torres Strait Islander Health Research
(www.lowitja.org.au), in partnership with the Queensland Insti-
tute of Medical Research (QIMR), sponsored the National Round-
table on Priorities for Aboriginal and Torres Strait Islander Cancer
Research conference. Leading cancer experts, Indigenous cancer
survivors and Indigenous community representatives shared infor-
mation about current research findings and tools, and about
expertise in Indigenous cancer research. Attempts were made to
clarify achievable, collaborative national research priorities for
better outcomes for Indigenous people with cancer and their
families and communities.
The National Roundtable built on momentum that has been
growing slowly but steadily over the past decade. In 2003, the first
review of cancer in Indigenous Australians highlighted its impor-
tance and identified the relative paucity of relevant research work.8
In 2004, the Cancer Council Australia, the peak non-government
body composed of state and territory cancer councils, convened the
first national discussion forum on Indigenous cancer.9 Throughout
the decade, research groups undertook important work relating to
health system performance for Indigenous people with can-
cer,2,3,5,10-12 but they largely worked in isolation from one another.
In 2007, Lancet Oncology commissioned a review of cancer in
Indigenous Australians,2 a much needed update to the 2003
review.8 In 2010, Cancer Australia, a federal government agency
formed in 2006 to drive national efforts in cancer control,
commissioned a comprehensive review of research and other
initiatives relating to cancer control in Indigenous Australians.3
Members of Cancer Australia’s Aboriginal and Torres Strait Islander
working group were included in the review project’s steeringber 10 • 16 May 2011
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31 recommendations.3 Subsequent discussions between QIMR,
the Lowitja Institute, members of the review team and a range of
other stakeholders resulted in the convening of the National
Roundtable.
Based on the discussions of National Roundtable participants,
there appears to be substantial agreement about what is needed for
productive progress. First and foremost, the involvement and
leadership of Indigenous people is critical. Second, we need to
work collaboratively and share lessons between jurisdictions,
institutions, researchers, policymakers, service providers and con-
sumers. Third, we need to clearly articulate shared research
priorities, emphasising work in:
• reducing risk (eg, effective tobacco control);
• identifying and implementing strategies that work in preven-
tive, diagnostic, therapeutic and palliative services;
• engaging Indigenous people and communities;
• improving cancer health literacy; and
• improving basic data infrastructure and monitoring capability
to measure progress and improve cancer care delivery.
National Roundtable participants envisaged a nationally inte-
grated and coordinated approach, in which new research builds
systematically on what has already been done, with audit, feed-
back and translation into behaviour as integral parts of the process.
An overarching governance arrangement was suggested to
address issues of strategic priorities and translation of collective
results of research to ensure its relevance and benefit. Indigenous
ownership of this governance arrangement, as opposed to a “top
down” government approach, was seen as crucial, as was partner-
ing with experts in relevant disciplines.
It was also agreed that the research agenda needed to be led by
Indigenous people, with its direction focusing firstly on cancers
with the largest gaps in survival. The realities of the “patient
journey” (eg, transport problems, racism, the broader social
determinants affecting an individual, and the importance of a
support person) could be used to assess the effectiveness of future
interventions.
Lastly, National Roundtable participants envisaged a move away
from state- or territory-based approaches or specific cancer-based
approaches towards more integrated, coordinated, systems-based
approaches to improve the quality of care. It was agreed that there is
an urgent need to identify the barriers against and enablers for
accurate identification of Indigenous status to improve accuracy of
data collection. We need to ensure that the internationally competi-
tive level of cancer management available to many Australians is also
accessible and culturally appropriate for Indigenous Australians.
It appears we now have a critical mass of people who under-
stand what needs to be done and who want to work together to
make it happen. Indeed, a large coalition of researchers, policy-
makers, service providers, consumer advocates and Indigenous
leaders is currently seeking funding to establish an integrated
program of applied research, stakeholder engagement, knowledge
transfer and training, based on the principles outlined above. Such
a collaborative effort would provide a much needed boost to our
individual efforts to improve Indigenous cancer control. We must
not squander the opportunity to make a lasting difference.
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